Status:
COMPLETED
Management of Atrial Fibrillation With Flecainide : the AFFLEC Study
Lead Sponsor:
Hellenic Cardiovascular Research Society
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-80 years
Brief Summary
This is a multicentre non interventional observational study with the objective to follow up patients with atrial fibrillation who based on current indications are treated with per os flecainide , for...
Detailed Description
the study objectives are * record safety and efficiency of flecainide as antiarrythmic treatment in atrial fibrillation * study of flecainide in ST interval
Eligibility Criteria
Inclusion
- patients with history of atrial fibrillation
- patients able to give informed consent
Exclusion
- patients with coronary disease or other cardiopathy with left heart champer affected
Key Trial Info
Start Date :
June 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02190175
Start Date
June 1 2014
End Date
December 1 2015
Last Update
September 7 2018
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Erythros Stavros Hospital
Athens, Greece, 11526
2
University Hospital of Larisa
Larissa, Greece, 41110
3
AHEPA University Hospital
Thessaloniki, Greece, 54636